Form 4: Phreesia Director Mark Smith Acquires 6,700 Restricted Stock Units

Phreesia, Inc. Director Mark Smith has acquired 6,700 Restricted Stock Units (RSUs) valued at $27.61 per share, bringing his total beneficial ownership to 37,353 shares, with vesting tied to future dates or board service cessation.

Summary

• Mark Douglas Smith, a Director of Phreesia, Inc. (PHR), acquired 6,700 shares of common stock on June 25, 2025.
• The acquisition was valued at $27.61 per share.
• These shares represent Restricted Stock Units (RSUs) issued under the Phreesia, Inc. 2019 Stock Option and Incentive Plan.
• Each RSU grants the contingent right to receive one share of the Issuer's common stock.
• Following this transaction, Mr. Smith directly beneficially owns 37,353 shares.
• The RSUs are scheduled to vest in full upon the earlier of June 25, 2026, or the next annual meeting of the Issuer's stockholders.
• Mr. Smith has elected to defer this grant through Phreesia, Inc.'s Non-Employee Director Deferred Compensation Program.
• The underlying common stock will be received on the earlier of 90 days after Mr. Smith ceases to serve as a director and incurs a 'separation from service' (as per Section 409A of the Internal Revenue Code), or five years from the RSU grant date.

Sentiment

Score: 7

Explanation: The document reports a routine grant of Restricted Stock Units (RSUs) to a director as part of their compensation. While not a direct open-market purchase, the acquisition of equity by an insider, even through a grant, is generally viewed as a neutral to slightly positive signal, indicating continued alignment of interests and confidence in the company's future.

Positives

• Director Mark Smith's acquisition of 6,700 Restricted Stock Units (RSUs) indicates continued alignment of management interests with shareholder value.
• The grant of RSUs under the 2019 Stock Option and Incentive Plan is a standard compensation practice that incentivizes long-term commitment and performance from board members.

Future Outlook

The acquired Restricted Stock Units are set to vest in full by the earlier of June 25, 2026, or the next annual meeting of stockholders. The underlying common stock will be received by the director either 90 days after ceasing board service and incurring a 'separation from service' or five years from the grant date of the deferred RSUs.

Industry Context

This Form 4 filing reflects a routine grant of Restricted Stock Units (RSUs) to a non-employee director, a common practice in the technology and healthcare IT sectors to align director incentives with long-term company performance. Such grants are part of standard corporate governance and compensation frameworks, aiming to retain experienced board members and encourage a focus on shareholder value.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) to a non-employee director is a standard compensation mechanism widely adopted across publicly traded companies, particularly in growth-oriented sectors like healthcare technology.
• This practice aligns with industry benchmarks for director compensation, which often include a mix of cash and equity to foster long-term commitment and incentivize performance.
• While specific comparable companies are not detailed in this filing, the structure of the RSU grant, including vesting schedules and deferral options, is consistent with best practices observed in companies of similar size and market capitalization within the healthcare IT space.

Corporate Governance

Related Party Transactions

• The acquisition of 6,700 Restricted Stock Units (RSUs) by Director Mark Smith is a related party transaction, representing equity compensation granted by Phreesia, Inc. to a member of its Board of Directors as part of his service.

Stakeholder Impact

• Shareholders: The RSU grant aims to align the director's interests with long-term shareholder value, potentially benefiting shareholders through improved governance and strategic decision-making.
• Shareholders: The future issuance of common stock upon RSU vesting could lead to minor dilution for existing shareholders.

Next Steps

• The Restricted Stock Units (RSUs) are scheduled to vest in full upon the earlier of June 25, 2026, or the next annual meeting of the Issuer's stockholders.
• The underlying common stock will be received by the director on the earlier of 90 days after ceasing board service and incurring a 'separation from service' or five years from the RSU grant date, due to the deferral election.

Key Dates

Keywords

Phreesia, PHR, Mark Smith, Director, Restricted Stock Units, RSU, SEC Form 4, Insider Transaction, Stock Option Plan, Deferred Compensation